SHIRE TO PRESENT NEW DATA AT ISTH 2017 TO ADVANCE THE STANDARD OF CARE IN HEMOPHILIA
Jun 23, 2017 12:07 pm UTC| Business
More than 35 presentations and sessions showcase Shire's gene therapy pipeline and leading factor portfolio Zug, Switzerland - June 23, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), a leading biotechnology company...
Creating the Center Store of the future
Jun 23, 2017 12:05 pm UTC| Business
COLORADO SPRINGS, Colo., June 23, 2017 -- Conventional retailers must rethink their stores and online strategies to satisfy how people really want to shop or risk fading into irrelevancy. Global Market Development...
Sky Solar Announces Change of Official Domain Name
Jun 23, 2017 12:00 pm UTC| Business
HONG KONG, June 23, 2017 -- Sky Solar Holdings, Ltd. (NASDAQ:SKYS) (“Sky Solar” or “the Company”), a global developer, owner and operator of solar parks, today announced that, effective immediately, its sole official...
Zignal Labs Integrates Critical Mention For Expanded Broadcast Media Coverage
Jun 23, 2017 12:00 pm UTC| Business
SAN FRANCISCO, June 23, 2017 -- Zignal Labs today announced it has integrated Critical Mention’s industry-leading television media data, broadening access to the full media spectrum for media intelligence and insights...
Semtech’s LoRa Technology Used by NNNCo to Develop Rural IoT Network for Australia’s Farmers
Jun 23, 2017 12:00 pm UTC| Business
CAMARILLO, Calif., June 23, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, announced its collaboration with National Narrowband Network Communications (NNNCo), a...
Lifetime Brands, Inc. Announces Results of 2017 Annual Meeting
Jun 23, 2017 12:00 pm UTC| Business
GARDEN CITY, N.Y., June 23, 2017 -- Lifetime Brands, Inc. (NasdaqGS:LCUT), a leading global provider of branded kitchenware, tableware and other products used in the home, announced the results of the votes taken at the...
Ovid Therapeutics to be Added to Russell 2000®, 3000® and Microcap® Indexes
Jun 23, 2017 12:00 pm UTC| Business
NEW YORK, June 23, 2017 -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that it will be added to the...